181 related articles for article (PubMed ID: 37311506)
1. Oral drug delivery: Influence of mucus on cellular interactions and uptake of lipid-based nanocarriers in Caco-2 cells.
Veider F; Knoll P; Jörgensen AM; Stengel D; Bernkop-Schnürch A
Acta Biomater; 2023 Sep; 167():416-424. PubMed ID: 37311506
[TBL] [Abstract][Full Text] [Related]
2. PEG vs. zwitterions: How these surface decorations determine cellular uptake of lipid-based nanocarriers.
Stengel D; Demirel BH; Knoll P; Truszkowska M; Laffleur F; Bernkop-Schnürch A
J Colloid Interface Sci; 2023 Oct; 647():52-64. PubMed ID: 37244176
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake of self-emulsifying drug-delivery systems: polyethylene glycol versus polyglycerol surface.
Friedl JD; Steinbring C; Zaichik S; Le NN; Bernkop-Schnürch A
Nanomedicine (Lond); 2020 Aug; 15(19):1829-1841. PubMed ID: 32781886
[No Abstract] [Full Text] [Related]
4. Zeta Potential Changing Polyphosphate Nanoparticles: A Promising Approach To Overcome the Mucus and Epithelial Barrier.
Akkus ZB; Nazir I; Jalil A; Tribus M; Bernkop-Schnürch A
Mol Pharm; 2019 Jun; 16(6):2817-2825. PubMed ID: 31070926
[TBL] [Abstract][Full Text] [Related]
5. Zeta potential changing nanoemulsions based on a simple zwitterion.
Sharifi F; Jahangiri M; Nazir I; Asim MH; Ebrahimnejad P; Hupfauf A; Gust R; Bernkop-Schnürch A
J Colloid Interface Sci; 2021 Mar; 585():126-137. PubMed ID: 33279695
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures.
Akbari A; Lavasanifar A; Wu J
Acta Biomater; 2017 Dec; 64():249-258. PubMed ID: 29030304
[TBL] [Abstract][Full Text] [Related]
7. Overcoming intestinal barriers by heparanase-responsive charge-converting nanocarriers.
Veider F; Zöller K; Saleh A; Bernkop-Schnürch A
Int J Pharm; 2024 Feb; 651():123817. PubMed ID: 38237708
[TBL] [Abstract][Full Text] [Related]
8. Replacing PEG-surfactants in self-emulsifying drug delivery systems: Surfactants with polyhydroxy head groups for advanced cytosolic drug delivery.
Friedl JD; Jörgensen AM; Nguyen Le NM; Steinbring C; Bernkop-Schnürch A
Int J Pharm; 2022 Apr; 618():121633. PubMed ID: 35304244
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
[TBL] [Abstract][Full Text] [Related]
11. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Intestinal Uptake And Permeability Of Fluorescently-Labelled Hyaluronic Acid Nanogels.
Xavier M; García-Hevia L; Amado IR; Pastrana L; Gonçalves C
Int J Nanomedicine; 2019; 14():9077-9088. PubMed ID: 31819420
[TBL] [Abstract][Full Text] [Related]
13. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
[TBL] [Abstract][Full Text] [Related]
14. Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption.
Liang Y; Ding R; Wang H; Liu L; He J; Tao Y; Zhao Z; Zhang J; Wang A; Sun K; Li Y; Shi Y
Drug Deliv; 2022 Dec; 29(1):305-315. PubMed ID: 35037529
[TBL] [Abstract][Full Text] [Related]
15. The interaction of protamine nanocapsules with the intestinal epithelium: A mechanistic approach.
Thwala LN; Beloqui A; Csaba NS; González-Touceda D; Tovar S; Dieguez C; Alonso MJ; Préat V
J Control Release; 2016 Dec; 243():109-120. PubMed ID: 27720993
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
17. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
Anderski J; Mahlert L; Mulac D; Langer K
Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525
[TBL] [Abstract][Full Text] [Related]
18. Zeta potential changing self-emulsifying drug delivery systems: A promising strategy to sequentially overcome mucus and epithelial barrier.
Nazir I; Fürst A; Lupo N; Hupfauf A; Gust R; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2019 Nov; 144():40-49. PubMed ID: 31505225
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro evaluation of zeta potential changing self-emulsifying drug delivery systems for enhanced mucus permeation.
Suchaoin W; Pereira de Sousa I; Netsomboon K; Lam HT; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2016 Aug; 510(1):255-62. PubMed ID: 27329673
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
